Pages that link to "Q46646221"

The following pages link to Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial (Q46646221):

Displaying 39 items.

• Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data? (Q34166896) (← links)
• Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment (Q34190076) (← links)
• Use of biologic agents in combination with other therapies for the treatment of psoriasis (Q34553755) (← links)
• Etanercept in the treatment of plaque psoriasis (Q34620263) (← links)
• Update of the management of chronic psoriasis: new approaches and emerging treatment options (Q34620375) (← links)
• A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in pa (Q36085078) (← links)
• Long-term efficacy of biologics in dermatology (Q37394846) (← links)
• A review of acitretin for the treatment of psoriasis (Q37649649) (← links)
• Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis (Q37724124) (← links)
• Acitretin revisited in the era of biologics (Q37776735) (← links)
• Combination therapy in the treatment of psoriasis (Q37792166) (← links)
• Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies. (Q38017725) (← links)
• Combination therapy in psoriasis: an evidence-based review. (Q38074846) (← links)
• A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. (Q38084325) (← links)
• Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials (Q38153077) (← links)
• Biological therapies for psoriasis (Q38155648) (← links)
• Acitretin in psoriasis: an evolving scenario (Q38193889) (← links)
• An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship. (Q38375060) (← links)
• Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis (Q38517070) (← links)
• Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects (Q38922128) (← links)
• Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update (Q39180810) (← links)
• A dermatologist guide to immunogenicity (Q39297511) (← links)
• Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries (Q40045451) (← links)
• Psoriasis in Solid Organ Transplant Patients: Best Practice Recommendations from the Medical Board of the National Psoriasis Foundation. (Q40060986) (← links)
• Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis (Q40283992) (← links)
• Transition of classical systemic treatments to etanercept (Q43056873) (← links)
• Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris. (Q43408664) (← links)
• Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin (Q44432805) (← links)
• Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept (Q44566796) (← links)
• Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study. (Q44669251) (← links)
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. (Q47260366) (← links)
• German S3-guidelines on the treatment of psoriasis vulgaris (short version). (Q48480123) (← links)
• Acitretin Use in Dermatology. (Q49793746) (← links)
• S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. (Q52888818) (← links)
• Emerging drugs for psoriasis (Q57244448) (← links)
• Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. (Q64903242) (← links)
• [Combined therapy with etanercept and systemic drugs or phototherapy] (Q84279851) (← links)
• Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis (Q89545337) (← links)
• Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response (Q92616693) (← links)